Insights

Acute ophthalmic focus Icon Bioscience specializes in novel ophthalmic pharmaceuticals via its Verisome drug-delivery platform, presenting a clear opportunity to expand partnerships with eye-care practitioners, clinics, and specialty distributors seeking advanced intraocular therapies.

Acquisition and rebranding Formerly independent, Icon Bioscience was acquired by pSivida and rebranded as EyePoint Pharmaceuticals, indicating a potential collaboration or channel alignment through EyePoint’s commercial footprint and existing ophthalmology sales network.

Early-stage momentum With a small team and revenue under one million, there is upside potential for strategic co-development deals, licensing opportunities, or co-marketing arrangements to accelerate pipeline products leveraging Verisome delivery.

Funding and partners Having raised substantial funding ($37M) but niche market scope, pursuing partnerships with larger ophthalmology players or contract development manufacturers could unlock scale, manufacturing capacity, and broader distribution.

Market positioning Target indications include macular edema, glaucoma, AMD, and cataract surgery — areas with high unmet need and active competition from larger pharma players, suggesting opportunities for licensing, joint development, or strategic alliances to access specialized ophthalmic segments.

Similar companies to Icon Bioscience, Inc.

Icon Bioscience, Inc. Tech Stack

Icon Bioscience, Inc. uses 8 technology products and services including WordPress, oEmbed, Cart Functionality, and more. Explore Icon Bioscience, Inc.'s tech stack below.

  • Content Management System
  • oEmbed
    Dev Tools
  • Cart Functionality
    E-commerce
  • Google Fonts API
    Font Scripts
  • Chart.js
    Javascript Graphics
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics

Icon Bioscience, Inc.'s Email Address Formats

Icon Bioscience, Inc. uses at least 2 email formats:
Icon Bioscience, Inc. Email FormatsExamplePercentage
FirstLast@iconbioscience.comJohnDoe@iconbioscience.com
83%
FirLast@iconbioscience.comJohDoe@iconbioscience.com
17%

Frequently Asked Questions

What is Icon Bioscience, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Icon Bioscience, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Icon Bioscience, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Icon Bioscience, Inc.'s official website is iconbioscience.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Icon Bioscience, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Icon Bioscience, Inc.'s annual revenue is estimated to be <$1M.

What is Icon Bioscience, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Icon Bioscience, Inc.'s SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Icon Bioscience, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Icon Bioscience, Inc. has approximately 2 employees across 1 continents, including North America. Key team members include Sr. Scientist In Analytical Chemistry: F. K. Explore Icon Bioscience, Inc.'s employee directory with LeadIQ.

What industry does Icon Bioscience, Inc. belong to?

Minus sign iconPlus sign icon
Icon Bioscience, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Icon Bioscience, Inc. use?

Minus sign iconPlus sign icon
Icon Bioscience, Inc.'s tech stack includes WordPress, oEmbed, Cart Functionality, Google Fonts API, Chart.js, Priority Hints, PHP and Google Analytics.

What is Icon Bioscience, Inc.'s email format?

Minus sign iconPlus sign icon
Icon Bioscience, Inc.'s email format typically follows the pattern of FirstLast@iconbioscience.com. Find more Icon Bioscience, Inc. email formats with LeadIQ.

How much funding has Icon Bioscience, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Icon Bioscience, Inc. has raised $37M in funding. The last funding round occurred on Dec 03, 2015 for $5.3M.
Icon Bioscience, Inc. logo

Icon Bioscience, Inc.

Pharmaceutical ManufacturingMassachusetts, United States2-10 Employees

Icon Bioscience, Inc. is a small pharmaceutical manufacturing company based in Watertown, Massachusetts. The firm is described in contemporary reporting as a specialty biopharmaceutical company. It maintains a website at iconbioscience.com. In March 2018, pSivida Corp. acquired Icon Bioscience, Inc. and announced plans to rebrand the business as EyePoint Pharmaceuticals.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $37M

    Icon Bioscience, Inc. has raised a total of $37M of funding over 3 rounds. Their latest funding round was raised on Dec 03, 2015 in the amount of $5.3M as a Convertible Note.

  • <$1M

    Icon Bioscience, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.